CC 152512: A Phase II, Single Arm, Multicenter Trial to Determine the Efficacy and Safety of CTL019 in Adult Patients with Relapsed or Refractory Diffuse Large B-cell Lymphoma (DLBCL)
Investigator: Charalambos (Babis) Andreadis, MD
Sponsor: Novartis Oncology
Location(s): United States
This is a multi-center, phase II study to determine the efficacy and safety of CTL019 in adult patients with relapsed or refractory DLBCL.